GenomeNet

Database: UniProt
Entry: Q9HB29
LinkDB: Q9HB29
Original site: Q9HB29 
ID   ILRL2_HUMAN             Reviewed;         575 AA.
AC   Q9HB29; A4FU63; Q13525; Q45H74; Q53TU8; Q587I8;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   07-FEB-2006, sequence version 2.
DT   04-NOV-2026, entry version 190.
DE   RecName: Full=Interleukin-1 receptor-like 2;
DE            EC=3.2.2.6 {ECO:0000255|PROSITE-ProRule:PRU00204};
DE   AltName: Full=IL-36 receptor;
DE            Short=IL-36R;
DE   AltName: Full=Interleukin-1 receptor-related protein 2;
DE            Short=IL-1Rrp2;
DE            Short=IL1R-rp2;
DE   Flags: Precursor;
GN   Name=IL1RL2; Synonyms=IL1RRP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10882729; DOI=10.1074/jbc.m004077200;
RA   Born T.L., Smith D.E., Garka K.E., Renshaw B.R., Bertles J.S., Sims J.E.;
RT   "Identification and characterization of two members of a novel class of the
RT   interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-
RT   related proteins based on signaling.";
RL   J. Biol. Chem. 275:29946-29954(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8898719; DOI=10.1016/s0165-5728(96)00047-1;
RA   Lovenberg T.W., Crowe P.D., Liu C., Chalmers D.T., Liu X.-J., Liaw C.,
RA   Clevenger W., Oltersdorf T., De Souza E.B., Maki R.A.;
RT   "Cloning of a cDNA encoding a novel interleukin-1 receptor related protein
RT   (IL1R-rp2).";
RL   J. Neuroimmunol. 70:113-122(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-352 AND PRO-550.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION AS RECEPTOR FOR IL36G.
RX   PubMed=11466363; DOI=10.4049/jimmunol.167.3.1440;
RA   Debets R., Timans J.C., Homey B., Zurawski S., Sana T.R., Lo S., Wagner J.,
RA   Edwards G., Clifford T., Menon S., Bazan J.F., Kastelein R.A.;
RT   "Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an
RT   antagonist and agonist of NF-kappa B activation through the orphan IL-1
RT   receptor-related protein 2.";
RL   J. Immunol. 167:1440-1446(2001).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=16646978; DOI=10.1186/ar1946;
RA   Magne D., Palmer G., Barton J.L., Mezin F., Talabot-Ayer D., Bas S.,
RA   Duffy T., Noger M., Guerne P.A., Nicklin M.J., Gabay C.;
RT   "The new IL-1 family member IL-1F8 stimulates production of inflammatory
RT   mediators by synovial fibroblasts and articular chondrocytes.";
RL   Arthritis Res. Ther. 8:R80-R80(2006).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=24829417; DOI=10.4049/jimmunol.1301481;
RA   Foster A.M., Baliwag J., Chen C.S., Guzman A.M., Stoll S.W.,
RA   Gudjonsson J.E., Ward N.L., Johnston A.;
RT   "IL-36 promotes myeloid cell infiltration, activation, and inflammatory
RT   activity in skin.";
RL   J. Immunol. 192:6053-6061(2014).
CC   -!- FUNCTION: Receptor for interleukin-36 (IL36A, IL36B and IL36G). After
CC       binding to interleukin-36 associates with the coreceptor IL1RAP to form
CC       the interleukin-36 receptor complex which mediates interleukin-36-
CC       dependent activation of NF-kappa-B, MAPK and other pathways (By
CC       similarity). The IL-36 signaling system is thought to be present in
CC       epithelial barriers and to take part in local inflammatory response; it
CC       is similar to the IL-1 system. Seems to be involved in skin
CC       inflammatory response by induction of the IL-23/IL-17/IL-22 pathway.
CC       {ECO:0000250|UniProtKB:Q9ERS7, ECO:0000269|PubMed:11466363}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + H2O = ADP-D-ribose + nicotinamide + H(+);
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC   -!- SUBUNIT: Interacts with IL1RAP; the association is enhanced by IL36B
CC       indicative for an functional signaling complex and inhibited by IL36RN
CC       (By similarity). {ECO:0000250|UniProtKB:Q9ERS7}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:24829417}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HB29-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB29-2; Sequence=VSP_056292, VSP_056293, VSP_056294;
CC   -!- TISSUE SPECIFICITY: Expressed in synovial fibroblasts and articular
CC       chondrocytes. Expressed in keratinocytes and monocyte-derived dendritic
CC       cells. Expressed in monocytes and myeloid dendritic cells; at protein
CC       level. {ECO:0000269|PubMed:16646978, ECO:0000269|PubMed:24829417}.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000255|PROSITE-ProRule:PRU00204}.
CC   -!- SIMILARITY: Belongs to the interleukin-1 receptor family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB53237.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF284434; AAG21368.1; -; mRNA.
DR   EMBL; U49065; AAB53237.1; ALT_FRAME; mRNA.
DR   EMBL; DQ131903; AAZ38712.1; -; Genomic_DNA.
DR   EMBL; AC007271; AAX81989.1; -; Genomic_DNA.
DR   EMBL; AC007248; AAY15046.1; -; Genomic_DNA.
DR   EMBL; BC107064; AAI07065.1; -; mRNA.
DR   CCDS; CCDS2056.1; -. [Q9HB29-1]
DR   CCDS; CCDS86867.1; -. [Q9HB29-2]
DR   PIR; G02426; G02426.
DR   RefSeq; NP_001338375.1; NM_001351446.2. [Q9HB29-1]
DR   RefSeq; NP_001338376.1; NM_001351447.1. [Q9HB29-2]
DR   RefSeq; NP_003845.2; NM_003854.4. [Q9HB29-1]
DR   PDB; 6U6U; X-ray; 2.31 A; R=21-215.
DR   PDB; 9ETH; X-ray; 2.30 A; R=20-220.
DR   PDB; 9ETI; X-ray; 2.40 A; R=20-220.
DR   AlphaFoldDB; Q9HB29; -.
DR   SMR; Q9HB29; -.
DR   BioGRID; 114336; 25.
DR   ComplexPortal; CPX-10338; Interleukin-36A receptor ligand complex.
DR   ComplexPortal; CPX-10340; Interleukin-36B receptor ligand complex.
DR   ComplexPortal; CPX-10341; Interleukin-36G receptor ligand complex.
DR   ComplexPortal; CPX-10343; Interleukin-36 antagonist complex.
DR   CORUM; Q9HB29; -.
DR   FunCoup; Q9HB29; 747.
DR   IntAct; Q9HB29; 6.
DR   NDEx; IQUERY-CP-IL1RL2; 2 NDEx IQuery Curated Pathways.
DR   STRING; 9606.ENSP00000264257; -.
DR   ChEMBL; CHEMBL4665591; -.
DR   DrugBank; DB15626; Spesolimab.
DR   DrugCentral; Q9HB29; -.
DR   GuidetoPHARMACOLOGY; 1736; -.
DR   GlyCosmos; Q9HB29; 10 sites, 1 glycan.
DR   GlyGen; Q9HB29; 10 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q9HB29; -.
DR   PhosphoSitePlus; Q9HB29; -.
DR   BioMuta; IL1RL2; -.
DR   DMDM; 90110768; -.
DR   jPOST; Q9HB29; -.
DR   MassIVE; Q9HB29; -.
DR   PaxDb; 9606-ENSP00000264257; -.
DR   PeptideAtlas; Q9HB29; -.
DR   ABCD; Q9HB29; 19 sequenced antibodies.
DR   Antibodypedia; 2361; 336 antibodies from 38 providers.
DR   DNASU; 8808; -.
DR   Ensembl; ENST00000264257.7; ENSP00000264257.2; ENSG00000115598.11. [Q9HB29-1]
DR   Ensembl; ENST00000441515.3; ENSP00000413348.2; ENSG00000115598.11. [Q9HB29-2]
DR   Ensembl; ENST00000908897.1; ENSP00000578956.1; ENSG00000115598.11. [Q9HB29-1]
DR   Ensembl; ENST00000908900.1; ENSP00000578959.1; ENSG00000115598.11. [Q9HB29-1]
DR   GeneID; 8808; -.
DR   KEGG; hsa:8808; -.
DR   MANE-Select; ENST00000264257.7; ENSP00000264257.2; NM_003854.4; NP_003845.2.
DR   UCSC; uc002tbs.4; human. [Q9HB29-1]
DR   AGR; HGNC:5999; -.
DR   ClinPGx; PA29815; -.
DR   CTD; 8808; -.
DR   DisGeNET; 8808; -.
DR   GeneCards; IL1RL2; -.
DR   HGNC; HGNC:5999; IL1RL2.
DR   HPA; ENSG00000115598; Tissue enhanced (skin).
DR   MIM; 604512; gene.
DR   OpenTargets; ENSG00000115598; -.
DR   VEuPathDB; HostDB:ENSG00000115598; -.
DR   eggNOG; ENOG502QWEU; Eukaryota.
DR   GeneTree; ENSGT01090000259985; -.
DR   HOGENOM; CLU_025552_3_0_1; -.
DR   InParanoid; Q9HB29; -.
DR   OMA; AAQDECK; -.
DR   OrthoDB; 6132459at2759; -.
DR   PAN-GO; Q9HB29; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9HB29; -.
DR   PathwayCommons; Q9HB29; -.
DR   Reactome; R-HSA-9007892; Interleukin-38 signaling.
DR   Reactome; R-HSA-9014826; Interleukin-36 pathway.
DR   SignaLink; Q9HB29; -.
DR   SIGNOR; Q9HB29; -.
DR   Agora; ENSG00000115598; -.
DR   BioGRID-ORCS; 8808; 16 hits in 1139 CRISPR screens.
DR   ChiTaRS; IL1RL2; human.
DR   GeneWiki; IL1RL2; -.
DR   GenomeRNAi; 8808; -.
DR   Pharos; Q9HB29; Tbio.
DR   PRO; PR:Q9HB29; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9HB29; protein.
DR   Bgee; ENSG00000115598; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 92 other cell types or tissues.
DR   ExpressionAtlas; Q9HB29; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0140368; C:decoy receptor complex; NAS:ComplexPortal.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:signaling receptor complex; IPI:ComplexPortal.
DR   GO; GO:0004908; F:interleukin-1 receptor activity; TAS:ProtInc.
DR   GO; GO:0004909; F:interleukin-1, type I, activating receptor activity; IEA:InterPro.
DR   GO; GO:0061809; F:NAD+ nucleosidase activity, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; NAS:ComplexPortal.
DR   GO; GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; NAS:ComplexPortal.
DR   GO; GO:0050727; P:regulation of inflammatory response; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd05757; Ig2_IL1R-like; 1.
DR   FunFam; 3.40.50.10140:FF:000002; Interleukin 1 receptor accessory protein; 1.
DR   FunFam; 2.60.40.10:FF:001096; Interleukin 1 receptor like 2; 1.
DR   FunFam; 2.60.40.10:FF:001302; Interleukin 1 receptor like 2; 1.
DR   FunFam; 2.60.40.10:FF:000188; Interleukin-1 receptor accessory protein-like 1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 3.40.50.10140; Toll/interleukin-1 receptor homology (TIR) domain; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR015621; IL-1_rcpt_fam.
DR   InterPro; IPR004076; IL-1_rcpt_I-typ.
DR   InterPro; IPR004074; IL-1_rcpt_I/II-typ.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR11890; INTERLEUKIN-1 RECEPTOR FAMILY MEMBER; 1.
DR   PANTHER; PTHR11890:SF9; INTERLEUKIN-1 RECEPTOR-LIKE 2; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   Pfam; PF01582; TIR; 1.
DR   PRINTS; PR01538; INTRLEUKN1R1.
DR   PRINTS; PR01536; INTRLKN1R12F.
DR   PRINTS; PR01537; INTRLKN1R1F.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   SUPFAM; SSF52200; Toll/Interleukin receptor TIR domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS50104; TIR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disulfide bond; Glycoprotein;
KW   Hydrolase; Immunity; Immunoglobulin domain; Inflammatory response;
KW   Innate immunity; Membrane; NAD; Proteomics identification; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..575
FT                   /note="Interleukin-1 receptor-like 2"
FT                   /id="PRO_0000015445"
FT   TOPO_DOM        20..335
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        336..356
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        357..575
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          20..111
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          126..211
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          222..318
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          381..536
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   ACT_SITE        467
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        59
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        109
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        127
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        234
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        250
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        266
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        299
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..95
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        146..195
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        249..316
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..46
FT                   /note="MWSLLLCGLSIALPLSVTADGCKDIFMKNEILSASQPFAFNCTFPP -> MT
FT                   GLVSLSYFPLSTRSCALQSCSPVWGCGPCCSAGCPSPFHCLSQQ (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056292"
FT   VAR_SEQ         47..163
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056293"
FT   VAR_SEQ         217..218
FT                   /note="TE -> K (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056294"
FT   VARIANT         237
FT                   /note="I -> T (in dbSNP:rs13405631)"
FT                   /id="VAR_053378"
FT   VARIANT         352
FT                   /note="V -> I (in dbSNP:rs33946385)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_025259"
FT   VARIANT         550
FT                   /note="L -> P (in dbSNP:rs2302612)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_025260"
FT   CONFLICT        486
FT                   /note="I -> V (in Ref. 1; AAG21368)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        545..556
FT                   /note="PPVQLLQHTPCY -> LRSTCRSTHLCTA (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        556
FT                   /note="Y -> C (in Ref. 1; AAG21368)"
FT                   /evidence="ECO:0000305"
FT   STRAND          23..27
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          31..36
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          38..41
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   TURN            45..48
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          53..59
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          61..63
FT                   /evidence="ECO:0007829|PDB:6U6U"
FT   STRAND          71..76
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          79..82
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          91..99
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          102..113
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   TURN            117..119
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          133..136
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          142..145
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          154..163
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          173..176
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          179..184
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   HELIX           187..189
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          191..201
FT                   /evidence="ECO:0007829|PDB:9ETH"
FT   STRAND          204..216
FT                   /evidence="ECO:0007829|PDB:9ETH"
SQ   SEQUENCE   575 AA;  65405 MW;  7AC0FCAB43A2A6CD CRC64;
     MWSLLLCGLS IALPLSVTAD GCKDIFMKNE ILSASQPFAF NCTFPPITSG EVSVTWYKNS
     SKIPVSKIIQ SRIHQDETWI LFLPMEWGDS GVYQCVIKGR DSCHRIHVNL TVFEKHWCDT
     SIGGLPNLSD EYKQILHLGK DDSLTCHLHF PKSCVLGPIK WYKDCNEIKG ERFTVLETRL
     LVSNVSAEDR GNYACQAILT HSGKQYEVLN GITVSITERA GYGGSVPKII YPKNHSIEVQ
     LGTTLIVDCN VTDTKDNTNL RCWRVNNTLV DDYYDESKRI REGVETHVSF REHNLYTVNI
     TFLEVKMEDY GLPFMCHAGV STAYIILQLP APDFRAYLIG GLIALVAVAV SVVYIYNIFK
     IDIVLWYRSA FHSTETIVDG KLYDAYVLYP KPHKESQRHA VDALVLNILP EVLERQCGYK
     LFIFGRDEFP GQAVANVIDE NVKLCRRLIV IVVPESLGFG LLKNLSEEQI AVYSALIQDG
     MKVILIELEK IEDYTVMPES IQYIKQKHGA IRWHGDFTEQ SQCMKTKFWK TVRYHMPPRR
     CRPFPPVQLL QHTPCYRTAG PELGSRRKKC TLTTG
//
DBGET integrated database retrieval system